Staff turmoil continues at Focus Surgery, the Milpitas, CA, developerof high-frequency ultrasound ablation products. The firm announcedlate last month that CFO John Kehoe has stepped down. His dutieswill be assumed temporarily by vice president of
Staff turmoil continues at Focus Surgery, the Milpitas, CA, developerof high-frequency ultrasound ablation products. The firm announcedlate last month that CFO John Kehoe has stepped down. His dutieswill be assumed temporarily by vice president of planning PaulSullivan.
Kehoe's departure came several weeks after Focus cut its workforce by 40% (SCAN 9/27/95). Focus has posted a string of losingquarters as it moves to commercialize its Sonablate 200 productfor treatment of benign prostatic hyperplasia. The company saidlast month that it "continues to examine all financing alternatives,"but declined to be more specific about what those alternativesmight be.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.